March mARKet Update Webinar Summary

During ARK’s March Market Update webinar, moderated by Portfolio Manager Dan White, CFA, ARK’s research team discussed developments shaping markets across several innovation platforms. The discussion addressed investors’ questions on space and defense, artificial intelligence, robotics, genomics, and bitcoin, highlighting both recent developments and long-term innovation trends. For further insights, please view the full webinar here.

We ran a poll on X asking what you wanted to hear about in this webinar, and the winner was Space & Defense…Here is a quick update on the Space & Defense industry overall, noting that the outlook may evolve quickly given current geopolitical developments and changes that occur between the time of recording this webinar and its publication.

Daniel Maguire, Research Analyst, Autonomous Technology & Robotics, explained that space and defense are converging as defense capabilities move into orbit. Recent conflicts have highlighted the effectiveness of low-cost autonomous systems, accelerating demand for unmanned solutions alongside traditional defense platforms. Simultaneously, declining launch costs driven largely by SpaceX are opening new opportunities in the space economy. Satellite connectivity has scaled significantly, and further cost reductions could enable new applications like orbital data centers.

In what year are you expecting Optimus to have an impact on Tesla’s earnings?

Tasha Keeney, Director of Investment Analysis and Institutional Strategies, noted that Tesla plans to begin low-volume production of Optimus in the near term, with higher-volume production expected to scale next year. In ARK’s view, however, robotaxis are likely to dominate Tesla’s earnings and valuation story over the next several years. As autonomous ride-hailing networks scale, Tesla could shift from hardware-driven margins to more software-like revenue streams. Over the longer term, humanoid robots could represent an even larger opportunity as capabilities improve.

What is your stance on the recent competitive landscape and shifts among OpenAI, Anthropic, and Microsoft, and how will that impact the three companies? 

Frank Downing, Director of Research, Next Generation Internet, noted that the frontier AI landscape currently includes OpenAI, Anthropic, xAI, and Google’s DeepMind. OpenAI and Google have built large consumer adoption, while Anthropic has gained traction in enterprise applications as AI agents become capable of completing longer tasks more reliably. Anthropic’s recent models have demonstrated improved performance in business environments, contributing to rapid revenue growth. Microsoft retains advantages through its cloud infrastructure and partnership with OpenAI but faces increasing competition from AI-native productivity platforms.

What do you think will catalyze performance in the ARK Genomic Revolution ETF ARKG? Will the multiomics market catch up to the rest of the innovation platforms?

Ovid Amadi, Multiomics Portfolio Manager and Director of Research, and Shea Wihlborg, Research Analyst, Multiomics, highlighted several catalysts that could support performance across the multiomics platform. These include increasing use of artificial intelligence in biological research, expanding reimbursement for advanced diagnostic testing, and growing datasets used in drug discovery. Clinical readouts and regulatory developments in genetic medicine also could provide important proof points for the space. In addition, pharmaceutical companies facing upcoming patent expirations may increase partnerships and acquisitions across biotechnology.

What is your near-term view on bitcoin?

David Puell, Research Trading Analyst / Associate Portfolio Manager, Digital Assets, discussed recent volatility in bitcoin and outlined ARK’s framework for evaluating the asset. The team considers regulatory developments, technical indicators, and on-chain data derived directly from the blockchain. David noted improving regulatory coordination between US agencies and highlighted on-chain signals that suggest strong underlying demand. While bitcoin has experienced a correction, ARK continues to view the long-term outlook constructively.

Do you believe it would have made more sense for xAI to merge with Tesla because then you could combine AI teams? The SpaceX and xAI merger gives an appearance that SpaceX will play favorites in deploying space compute. Is there a monopoly risk to merging these companies?

Tasha Keeney explained that Tesla and xAI technologies could complement each other, particularly as AI models support autonomous systems like robotaxis and robotics. That said, ARK’s research suggests that Tesla’s robotaxi opportunity may be best realized as a standalone public company before deeper integration occurs. Vertical integration across Musk’s companies could offer strategic advantages in areas like compute and infrastructure, but for now, the companies operate in distinct markets, making potential regulatory concerns difficult to assess.

Recursion (RXRX) has been an underperformer recently. What do you think will turn the stock around?

Shea Wihlborg highlighted several developments that could serve as catalysts for Recursion. The company recently appointed Najat Khan as Chief Executive Officer, bringing experience in applying AI across pharmaceutical research and development. Recursion also has reduced operating expenses and implemented a more disciplined budgeting framework to extend its runway. Upcoming clinical milestones, regulatory engagement, and continued partnerships with pharmaceutical companies could help validate Recursion’s AI-driven drug discovery platform.

Conclusion:

Across the questions in this update, a consistent theme emerged: innovation is moving from theory to real-world deployment across multiple sectors at once. From space and defense to AI, robotics, multiomics, and bitcoin, recent developments continue to reinforce our view that declining costs, stronger data advantages, and improving technology capabilities are expanding long-term opportunities, even as near-term uncertainty and volatility persist. At ARK, we remain focused on the research, signals, and converging innovation platforms we believe are shaping the future of markets.

Make sure to check out our In The Know video series for deeper insights.

Important Information

Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ARK Fund before investing. This and other information are contained in the ARK Funds’ prospectuses and summary prospectuses, which may be obtained by clicking here. The prospectus and summary prospectus should be read carefully before investing. 

An investment in an ARK Fund is subject to risks and you can lose money on your investment in an ARK Fund. There can be no assurance that the ARK Funds will achieve their investment objectives. The ARK Funds’ portfolios are more volatile than broad market averages. The ARK Funds also have specific risks, which are described in their respective prospectuses. 

The ARK DIET Buffer ETFs have characteristics unlike traditional investment products and are not suitable for all investors.

The information provided in this material is for informational purposes only and should not be used as the basis for any investment decision and is subject to change without notice. It does not constitute, either explicitly or implicitly, any provision of services or products by ARK, and investors should determine for themselves whether a particular investment management service is suitable for their investment needs. All statements made regarding companies or securities are strictly beliefs and points of view held by ARK and are not endorsements by ARK of any company or security or recommendations by ARK to buy, sell or hold any security. Historical results are not indications of future results. 

Certain of the statements contained in this material may be statements of future expectations and other forward-looking statements that are based on ARK's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. ARK assumes no obligation to update any forward-looking information. ARK and its clients as well as its related persons may (but do not necessarily) have financial interests in securities or issuers that are discussed. Certain information was obtained from sources that ARK believes to be reliable; however, ARK does not guarantee the accuracy or completeness of any information obtained from any third party.

Digital assets, often referred to as cryptocurrencies, such as bitcoin and ether are relatively new investments, which have unique and substantial risks and which may be more volatile than other types of investments. ARK strongly encourages any investor considering an investment in any digital asset to consult with a financial professional before investing. All statements made regarding digital assets are strictly beliefs and points of view held by ARK and are not recommendations by ARK to buy, sell or hold any digital asset. Historical results are not indications of future results.

To view the top ten holdings for ARKK click here.

To view the top ten holdings for ARKQ click here.

To view the top ten holdings for ARKW click here.

To view the top ten holdings for ARKG click here.

To view the top ten holdings for ARKF click here.

To view the top ten holdings for ARKX click here.

To view the top ten holdings for ARKVX click here.

Holdings are subject to change

Foreside Fund Services, LLC, distributor.